KOR
ENG
Home / Customer Support / FAQ
Qualitative test for COVID-19 IgG/IgM Duo
The FREND™ COVID-19 IgG/IgM Duo is designed for the qualitative detection of anti-coronavirus IgG and IgM in human serum and plasma (Li-heparinized, EDTA, or citrate) by fluorescence immunoassay (FIA) using the FREND™ System. FREND™ COVID 19 IgG/IgM Duo is an in vitro diagnostic medical device that helps identify coronavirus disease 2019 (COVID-19) infections.
KEY FEATURES & BENEFITS
- 3 minutes | Fast result
- 2 steps | Easy to use
- 93.02% & 100% | Positive & Negative Percent Agreement
(after 8 days from symptom onset)
- Microfluidic Qualitative Immunoassay
- LIS connectivity (data management)
